scispace - formally typeset
Open AccessJournal ArticleDOI

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-up

Behnood Bikdeli, +50 more
- 16 Jun 2020 - 
- Vol. 75, Iss: 23, pp 2950-2973
TLDR
The current understanding of the pathogenesis, epidemiology, management and outcomes of patients with COVID-19 who develop venous or arterial thrombosis, and of those with preexistingThrombotic disease who develop CO VID-19 are reviewed.
About
This article is published in Journal of the American College of Cardiology.The article was published on 2020-06-16 and is currently open access. It has received 2222 citations till now. The article focuses on the topics: Platelet activation & Antithrombotic.

read more

Citations
More filters
Journal ArticleDOI

COVID-19 and its implications for thrombosis and anticoagulation.

TL;DR: COVID-19–associated coagulopathy should be managed as it would be for any critically ill patient, following the established practice of using thromboembolic prophylaxis for critically ill hospitalized patients, and standard supportive care measures for those with sepsis-induced coagULopathy or DIC.
References
More filters
Journal ArticleDOI

Cancer therapy and cardiovascular risk: focus on bevacizumab.

TL;DR: This review will focus on the cardiovascular toxicity of bevacizumab, providing the latest evidence on the incidence, clinical spectrum, risk factors, and responsible mechanisms.
Journal ArticleDOI

Warfarin Dose Assessment Every 4 Weeks Versus Every 12 Weeks in Patients With Stable International Normalized Ratios: A Randomized Trial

TL;DR: In this paper, the authors investigated whether assessment of warfarin dosing every 12 weeks is as safe as assessment every 4 weeks and concluded that it is not necessary for patients to undergo international normalized ratio (INR) monitoring every four weeks.
Journal ArticleDOI

Physical inactivity and idiopathic pulmonary embolism in women: prospective study

TL;DR: Physical inactivity is associated with incident pulmonary embolism in women and interventions that decrease time sitting could lower the risk of pulmonary emblism.
Journal ArticleDOI

Efficacy and safety of weight-adjusted heparin prophylaxis for the prevention of acute venous thromboembolism among obese patients undergoing bariatric surgery: A systematic review and meta-analysis

TL;DR: Adjusting the dose of heparin products for thromboprophylaxis post-bariatric surgery seems to be associated with a lower rate of in hospital VTE compared to a strategy of not adjusting the dose, although this did not reach statistical significance.
Related Papers (5)